Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Davide Papola, Ph.D., M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gastaldon C, Schoretsanitis G, Arzenton E, Raschi E, Papola D, Ostuzzi G, Moretti U, Seifritz E, Kane JM, Trifirò G, Barbui C. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database. Drug Saf. 2022 Dec; 45(12):1539-1549. PMID: 36400895; PMCID: PMC9676852.
    Citations:    Fields:    
  2. Tarsitani L, Pinucci I, Tedeschi F, Patanè M, Papola D, Palantza C, Acarturk C, Björkenstam E, Bryant R, Burchert S, Davisse-Paturet C, Díaz-García A, Farrel R, Fuhr DC, Hall BJ, Huizink AC, Lam AIF, Kurt G, Leijen I, Mittendorfer-Rutz E, Morina N, Panter-Brick C, Purba FD, Quero S, Seedat S, Setyowibowo H, van der Waerden J, Pasquini M, Sijbrandij M, Barbui C. Resilience of people with chronic medical conditions during the COVID-19 pandemic: a 1-year longitudinal prospective survey. BMC Psychiatry. 2022 10 01; 22(1):633. PMID: 36183067; PMCID: PMC9525930.
    Citations:    Fields:    Translation:HumansPHPublic Health
  3. Gastaldon C, Arzenton E, Raschi E, Spigset O, Papola D, Ostuzzi G, Moretti U, Trifirò G, Barbui C, Schoretsanitis G. Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database. Psychol Med. 2022 Sep 21; 1-9. PMID: 36128628.
    Citations:    Fields:    
  4. Papola D, Ostuzzi G, Tedeschi F, Gastaldon C, Purgato M, Del Giovane C, Pompoli A, Pauley D, Karyotaki E, Sijbrandij M, Furukawa TA, Cuijpers P, Barbui C. Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. Br J Psychiatry. 2022 09; 221(3):507-519. PMID: 35049483.
    Citations: 1     Fields:    Translation:Humans
  5. Feller D, Fox I, Gozzer P, Trentin F, Papola D. Exercise for Depressive Symptoms in Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arch Phys Med Rehabil. 2022 Aug 27. PMID: 36030894.
    Citations:    Fields:    
  6. Cuijpers P, Miguel C, Papola D, Harrer M, Karyotaki E. From living systematic reviews to meta-analytical research domains. Evid Based Ment Health. 2022 Jul 19. PMID: 35853730; PMCID: PMC9685685.
    Citations:    Fields:    
  7. Ostuzzi G, Vita G, Bertolini F, Tedeschi F, De Luca B, Gastaldon C, Nosé M, Papola D, Purgato M, Del Giovane C, Correll CU, Barbui C. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis. Lancet Psychiatry. 2022 08; 9(8):614-624. PMID: 35753323.
    Citations: 2     Fields:    Translation:Humans
  8. Turrini G, Purgato M, Tedeschi F, Acartürk C, Anttila M, Au T, Carswell K, Churchill R, Cuijpers P, Friedrich F, Gastaldon C, Klein T, Kösters M, Lantta T, Nosè M, Ostuzzi G, Papola D, Popa M, Sijbrandij M, Tarsitani L, Todini L, Uygun E, Välimäki M, Walker L, Wancata J, White RG, Zanini E, van Ommeren M, Barbui C. Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial. Epidemiol Psychiatr Sci. 2022 Jun 08; 31:e39. PMID: 35674122; PMCID: PMC9220789.
    Citations:    Fields:    Translation:Humans
  9. Ostuzzi G, Bertolini F, Tedeschi F, Vita G, Brambilla P, Del Fabro L, Gastaldon C, Papola D, Purgato M, Nosari G, Del Giovane C, Correll CU, Barbui C. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants. World Psychiatry. 2022 Jun; 21(2):295-307. PMID: 35524620; PMCID: PMC9077618.
    Citations: 2     
  10. Gémes K, Bergström J, Papola D, Barbui C, Lam AIF, Hall BJ, Seedat S, Morina N, Quero S, Campos D, Pinucci I, Tarsitani L, Deguen S, van der Waerden J, Patanè M, Sijbrandij M, Acartürk C, Burchert S, Bryant RA, Mittendorfer-Rutz E. Symptoms of anxiety and depression during the COVID-19 pandemic in six European countries and Australia - Differences by prior mental disorders and migration status. J Affect Disord. 2022 08 15; 311:214-223. PMID: 35598751; PMCID: PMC9119165.
    Citations:    Fields:    Translation:HumansPHPublic Health
  11. Ostuzzi G, Gastaldon C, Papola D, Barbui C. Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries. Epidemiol Psychiatr Sci. 2022 May 11; 31:e34. PMID: 35543395; PMCID: PMC9121849.
    Citations:    Fields:    Translation:Humans
  12. Wright SL, Karyotaki E, Bisson JI, Cuijpers P, Papola D, Witteveen AB, Seedat S, Sijbrandij M. Protocol for individual participant data meta-analysis of interventions for post-traumatic stress. BMJ Open. 2022 Feb 15; 12(2):e054830. PMID: 35168977; PMCID: PMC8852733.
    Citations:    Fields:    Translation:Humans
  13. Purgato M, Carswell K, Tedeschi F, Acarturk C, Anttila M, Au T, Bajbouj M, Baumgartner J, Biondi M, Churchill R, Cuijpers P, Koesters M, Gastaldon C, Ilkkursun Z, Lantta T, Nosè M, Ostuzzi G, Papola D, Popa M, Roselli V, Sijbrandij M, Tarsitani L, Turrini G, Välimäki M, Walker L, Wancata J, Zanini E, White R, van Ommeren M, Barbui C. Effectiveness of Self-Help Plus in Preventing Mental Disorders in Refugees and Asylum Seekers in Western Europe: A Multinational Randomized Controlled Trial. Psychother Psychosom. 2021; 90(6):403-414. PMID: 34350902; PMCID: PMC8619740.
    Citations: 11     Fields:    Translation:Humans
  14. Pauley D, Cuijpers P, Papola D, Miguel C, Karyotaki E. Two decades of digital interventions for anxiety disorders: a systematic review and meta-analysis of treatment effectiveness. Psychol Med. 2021 May 28; 1-13. PMID: 34047264.
    Citations: 2     Fields:    
  15. Ostuzzi G, Bertolini F, Del Giovane C, Tedeschi F, Bovo C, Gastaldon C, Nosé M, Ogheri F, Papola D, Purgato M, Turrini G, Correll CU, Barbui C. Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. Am J Psychiatry. 2021 05 01; 178(5):424-436. PMID: 33596679.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  16. Papola D, Ostuzzi G, Gastaldon C, Purgato M, Del Giovane C, Pompoli A, Karyotaki E, Sijbrandij M, Furukawa TA, Cuijpers P, Barbui C. Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses. BMJ Open. 2020 12 28; 10(12):e038909. PMID: 33372071.
    Citations:    Fields:    Translation:Humans
  17. Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Serdar D, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Safety of Psychotropic Medications in People With COVID-19: Evidence Review and Practical Recommendations. Focus (Am Psychiatr Publ). 2020 Oct; 18(4):466-481. PMID: 33343260; PMCID: PMC7725161.
    Citations: 3     
  18. Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med. 2020 09 12; 18(1):291. PMID: 32919477; PMCID: PMC7486584.
    Citations: 2     Fields:    
  19. Papola D, Purgato M, Gastaldon C, Bovo C, van Ommeren M, Barbui C, Tol WA. Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises. Cochrane Database Syst Rev. 2020 09 08; 9:CD012417. PMID: 32897548; PMCID: PMC8094402.
    Citations: 18     Fields:    Translation:Humans
  20. Ostuzzi G, Gastaldon C, Barbato A, D'Avanzo B, Tettamanti M, Monti I, Aguglia A, Aguglia E, Alessi MC, Amore M, Bartoli F, Biondi M, Bortolaso P, Callegari C, Carrà G, Caruso R, Cavallotti S, Crocamo C, D'Agostino A, De Fazio P, Di Natale C, Giusti L, Grassi L, Martinotti G, Nosé M, Papola D, Purgato M, Rodolico A, Roncone R, Tarsitani L, Turrini G, Zanini E, Amaddeo F, Ruggeri M, Barbui C. Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial. Trials. 2020 Aug 03; 21(1):695. PMID: 32746941; PMCID: PMC7397635.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  21. Ostuzzi G, Gastaldon C, Papola D, Fagiolini A, Dursun S, Taylor D, Correll CU, Barbui C. Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Ther Adv Psychopharmacol. 2020; 10:2045125320942703. PMID: 32733668; PMCID: PMC7372613.
    Citations: 8     
  22. Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med. 2020 07 15; 18(1):215. PMID: 32664944; PMCID: PMC7360478.
    Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
  23. Gastaldon C, Papola D, Ostuzzi G, Barbui C. Esketamine clinical trials: reply to Maju et al. Epidemiol Psychiatr Sci. 2020 Apr 29; 29:e122. PMID: 32345395; PMCID: PMC7214734.
    Citations: 1     Fields:    Translation:Humans
  24. Morgano GP, Fulceri F, Nardocci F, Barbui C, Ostuzzi G, Papola D, Fatta LM, Fauci AJ, Coclite D, Napoletano A, De Crescenzo F, D'Alò GL, Amato L, Cinquini M, Iannone P, Schünemann HJ, Scattoni ML. Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health. Health Qual Life Outcomes. 2020 Mar 26; 18(1):81. PMID: 32216833; PMCID: PMC7098105.
    Citations: 3     Fields:    Translation:Humans
  25. Barbui C, Purgato M, Abdulmalik J, Acarturk C, Eaton J, Gastaldon C, Gureje O, Hanlon C, Jordans M, Lund C, Nosè M, Ostuzzi G, Papola D, Tedeschi F, Tol W, Turrini G, Patel V, Thornicroft G. Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review. Lancet Psychiatry. 2020 02; 7(2):162-172. PMID: 31948935.
    Citations: 54     Fields:    Translation:Humans
  26. Cuijpers P, Quero S, Papola D, Cristea IA, Karyotaki E. Care-as-usual control groups across different settings in randomized trials on psychotherapy for adult depression: a meta-analysis. Psychol Med. 2021 03; 51(4):634-644. PMID: 31843031.
    Citations: 5     Fields:    Translation:Humans
  27. Gastaldon C, Papola D, Ostuzzi G, Barbui C. Esketamine for treatment resistant depression: a trick of smoke and mirrors? Epidemiol Psychiatr Sci. 2019 Dec 16; 29:e79. PMID: 31841104; PMCID: PMC8061126.
    Citations: 12     Fields:    Translation:Humans
  28. Purgato M, Tedeschi F, Betancourt TS, Bolton P, Bonetto C, Gastaldon C, Gordon J, O'Callaghan P, Papola D, Peltonen K, Punamaki RL, Richards J, Staples JK, Unterhitzenberger J, de Jong J, Jordans MJD, Gross AL, Tol WA, Barbui C. Mediators of focused psychosocial support interventions for children in low-resource humanitarian settings: analysis from an Individual Participant Dataset with 3,143 participants. J Child Psychol Psychiatry. 2020 05; 61(5):584-593. PMID: 31701533.
    Citations: 4     Fields:    Translation:Humans
  29. Papola D, Ostuzzi G, Gastaldon C, Morgano GP, Dragioti E, Carvalho AF, Fusar-Poli P, Correll CU, Solmi M, Barbui C. Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies. Acta Psychiatr Scand. 2019 09; 140(3):227-243. PMID: 31264708.
    Citations: 22     Fields:    Translation:Humans
  30. Tsujimoto Y, Tsutsumi Y, Kataoka Y, Tsujimoto H, Yamamoto Y, Papola D, Guyatt GH, Fukuhara S, Furukawa TA. Statistical significance did not affect time to publication in non-Cochrane systematic reviews: a metaepidemiological study. J Clin Epidemiol. 2019 11; 115:25-34. PMID: 31276781.
    Citations: 2     Fields:    Translation:Humans
  31. Purgato M, Carswell K, Acarturk C, Au T, Akbai S, Anttila M, Baumgartner J, Bailey D, Biondi M, Bird M, Churchill R, Eskici S, Hansen LJ, Heron P, Ilkkursun Z, Kilian R, Koesters M, Lantta T, Nosè M, Ostuzzi G, Papola D, Popa M, Sijbrandij M, Tarsitani L, Tedeschi F, Turrini G, Uygun E, Välimäki MA, Wancata J, White R, Zanini E, Cuijpers P, Barbui C, Van Ommeren M. Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials. BMJ Open. 2019 05 14; 9(5):e030259. PMID: 31092670; PMCID: PMC6530324.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  32. Ostuzzi G, Turrini G, Gastaldon C, Papola D, Rayner L, Caruso R, Grassi L, Hotopf M, Barbui C. Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis. Int Clin Psychopharmacol. 2019 03; 34(2):65-75. PMID: 30531552.
    Citations: 4     Fields:    Translation:Humans
  33. Barbui C, Papola D, Saraceno B. The Italian mental health-care reform: public health lessons. Bull World Health Organ. 2018 Nov 01; 96(11):731-731A. PMID: 30455525; PMCID: PMC6239006.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  34. Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nosé M, Ostinelli EG, Papola D, Piccinelli MP, Piccoli A, Purgato M, Tabacchi T, Turrini G, Ruggeri M, Barbui C. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PLoS One. 2018; 13(8):e0201371. PMID: 30071042; PMCID: PMC6072022.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  35. Barbui C, Papola D, Saraceno B. Forty years without mental hospitals in Italy. Int J Ment Health Syst. 2018; 12:43. PMID: 30079100; PMCID: PMC6069799.
    Citations: 10     
  36. Purgato M, Gastaldon C, Papola D, van Ommeren M, Barbui C, Tol WA. Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises. Cochrane Database Syst Rev. 2018 07 05; 7:CD011849. PMID: 29975811; PMCID: PMC6513488.
    Citations: 54     Fields:    Translation:Humans
  37. Papola D, Ostuzzi G, Thabane L, Guyatt G, Barbui C. Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies. Int Clin Psychopharmacol. 2018 07; 33(4):181-196. PMID: 29688914.
    Citations: 7     Fields:    Translation:Humans
  38. Purgato M, Gross AL, Betancourt T, Bolton P, Bonetto C, Gastaldon C, Gordon J, O'Callaghan P, Papola D, Peltonen K, Punamaki RL, Richards J, Staples JK, Unterhitzenberger J, van Ommeren M, de Jong J, Jordans MJD, Tol WA, Barbui C. Focused psychosocial interventions for children in low-resource humanitarian settings: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2018 04; 6(4):e390-e400. PMID: 29530422.
    Citations: 37     Fields:    Translation:Humans
  39. Papola D, Gastaldon C, Ostuzzi G. Can a digital medicine system improve adherence to antipsychotic treatment? Epidemiol Psychiatr Sci. 2018 06; 27(3):227-229. PMID: 29528032; PMCID: PMC6998860.
    Citations: 2     Fields:    Translation:Humans
  40. Tsujimoto Y, Tsutsumi Y, Kataoka Y, Tsujimoto H, Yamamoto Y, Papola D, Guyatt GH, Fukuhara S, Furukawa TA. Association between statistical significance and time to publication among systematic reviews: a study protocol for a meta-epidemiological investigation. BMJ Open. 2017 Oct 22; 7(10):e018856. PMID: 29061634; PMCID: PMC5665249.
    Citations: 4     Fields:    Translation:Humans
  41. Sadeghirad B, Siemieniuk RAC, Brignardello-Petersen R, Papola D, Lytvyn L, Vandvik PO, Merglen A, Guyatt GH, Agoritsas T. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. BMJ. 2017 Sep 20; 358:j3887. PMID: 28931508; PMCID: PMC5605780.
    Citations: 15     Fields:    Translation:Humans
  42. Gastaldon C, Papola D, Ostuzzi G. Antipsychotic combinations in schizophrenia. Epidemiol Psychiatr Sci. 2017 10; 26(5):462-465. PMID: 28578741; PMCID: PMC6998900.
    Citations:    Fields:    Translation:Humans
  43. Ostuzzi G, Papola D, Gastaldon C, Barbui C. New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base. Epidemiol Psychiatr Sci. 2017 06; 26(3):231-233. PMID: 28004623; PMCID: PMC6998643.
    Citations: 10     Fields:    Translation:Humans
  44. Barbui C, Gastaldon C, Papola D, Ostuzzi G. Antipsychotic drug exposure and risk of myocardial infarction. Epidemiol Psychiatr Sci. 2017 02; 26(1):18-21. PMID: 27873561; PMCID: PMC7137645.
    Citations: 3     Fields:    Translation:Humans
  45. Purgato M, Gastaldon C, Papola D, Magni LR, Rossi G, Barbui C. Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine. Acta Psychiatr Scand. 2015 Jun; 131(6):408-16. PMID: 25495269.
    Citations: 2     Fields:    Translation:Humans
  46. Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C. Paroxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev. 2014 Apr 03; (4):CD006531. PMID: 24696195.
    Citations: 17     Fields:    Translation:Humans
  47. Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. 2013 Jul 17; (7):CD004185. PMID: 24353997.
    Citations: 24     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Papola's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (137)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.